Patient-derived xenograft models to optimize kidney cancer therapies

DOI: 10.21037/tau.2018.11.04

Keywords: Orthotopic, patient-derived xenograft (PDX), renal cell carcinoma (RCC)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text